¿­·¢K8Æì½¢Ìü

À´Ô´£ºÔç½ÌÓý¶ùÊé £¬×÷Õߣº  £¬£º

ÚÀѽ¸çÃǶù £¬ÄãÖªµÀ²» £¬×î½üÎÒ¹ëÅ®¸úÎÒßë £¬ËµËýͬѧÀÏÌáɶ¡°Ö£Öݲè�ÂÛ̳¡± £¬ÎÒÒ»Ìý¿ÉÏ¡º±ÁË¡£Õâ²è�ÂÛ̳ £¬Ìý×ÅÕ¦ÁíÓеãÏñÔÛÕâ¶ùÄÇÀÏÄêÔ˶¯ÖÐÐÄÄØ £¬ÊDz» £¿ÎÒѰ˼×Å £¬ÕâÍæÒâ¶ù¿Ï¶¨²»¿ÉÊÇÆ·ÜøÁÄÏÐÆª¶ùÄÇô¼òµ¥ß £¬ÀïÃæÖ¸¶¨ÓеãÃŵÀ¶ù £¬½ñÌì¾Í¸úÄãßëßëÕâ¸öʶù¡£

Ö£Öݲè�ÂÛ̳ £¬Õ¦¸ö»ØÊ¶ù £¿

Æäʵ°¡ £¬Ö£Öݲè�ÂÛ̳Ëü²»¿ÉÊǸöµØ¶ù £¬ÕվɸöȦ¶ù¡£Äã¿´ £¬ÔÛ¶«±±µÄÉÕ¿¾Ì¯¶ù°É £¬³ÔµÄÄÇÊÇÉÕ¿¾ £¬¿ÉÖ÷ÒªÊǸéÄǶùßëྠ£¬ÕûµãÈ˼ʹØÏµÉ¶µÄ £¬Ö£Öݲè�ÂÛ̳ҲÊDzîδ¼¸¡£ËüÊǸöÏßÉÏÆ½Ì¨ £¬¾ÛÁËÒ»°ïÈË £¬É¶È˶¼ÓÐ £¬Æ·ÜøµÄ¡¢×öÉúÒâµÄ¡¢ÁÄÈËÉúµÄ £¬¸úÔÛ¶«±±´ó¼¯ËƵÄ £¬É¶ÍæÒâ¶ù¶¼ÄÜÅö×Å¡£

ÎÒÄêÇáÄÇ»á¶ù £¬ÔÛÕâ¶ùÒ²ÓÐÀàËÆµÄµØ·½ £¬ÏñɶÀϵÀÍâµÄ²è�¶ù £¬È¥ÄǶù¸é×ÅÁÄÌì £¬ÌýÏûÏ¢ £¬ÉõÖÁ»¹ÄÜÅöÉÏÄÜÈ˶ù¸øÄãÖ¸µãµã¶ùÃŵÀ¶ù £¬ÀÏ´ø¾¢ÁË¡£Ö£Öݲè�ÂÛ̳°É £¬¾ÍÊǸøÕâЩÀϲè¿ÍÕûµ½ÍøÉÏÈ¥ÁË¡£ÄãÉÏÂÛ̳Áï´ïÁï´ï £¬¿ÉÄÜ»¹ÄÜÕûµãÉÌ»ú £¬Äã˵ÊDz» £¿

ÀïÃæÓÐɶÃŵÀ¶ù £¬ÌýÎÒ˵˵

ßëྺ͡°ÈËÇéζ¶ù¡± £¬Õâ²ÅÊÇÕý¾­Ê¶ù

ÎÒ¸úÄã½²°¡ £¬ÕâÂÛ̳ÀïÍ·µÄßëྠ£¬ÄǽÐÒ»¸öÓÐÒâ˼¡£É¶¶¼ÄÜÁÄ £¬Æ·ÜøµÄ½²¾¿¡¢µØ·½µÄÃñË× £¬ÁíÓеã×ÓʶùɶµÄ¡ £¿É±ðÐ¡ÇÆÕâЩÁÄÌìÄÅ £¬Ðí¶àÈËÉÏÂÛ̳ £¬ÕæÕýµÄÄ¿µÄ²»ÊÇÆ·Üø £¬¶øÊÇΪÁËÕûÈËÇé¹ØÏµ¡£Õâ¾Í¸úÔÛÃǶ«±±È˳öÈ¥³ÔÉÕ¿¾ËƵÄ £¬³Ô²»ÊÇÖ÷ÒªµÄ £¬Ö÷ÒªÊǽ»ÅóÓÑ £¬ÕûµãÈËÇéζ¶ù¡£

ÇÄÃþ¸æËßÄã°¡ £¬ÎÒÌýËÃ÷ÈÕâÂÛ̳ÉÏÁíÓС°²è�Çпڡ± £¬¾Í¸úÔÛÃÇÕâ¶ùÀÏÂë×ÓËÆµÄ £¬É¶¡°Ò¹À´Ï㡱¡¢¡°°ëºøÀϾơ± £¬ÕâЩ´ÊÒ»Ìý¾ÍÊÇÓн²¾¿µÄ¡£¶®ÐеÄÈËÒ»¿´¾ÍÖªµÀ £¬ÄãÊÇȦÀïÈË £¬ÕÕ¾ÉÍâ±ß¶ùÏ¹×ªÓÆµÄ¡£

±ðäĿ¼ÓÈë £¬ÏÈ̽ѯ̽ѯ

Ïà¹ØÍ¼Æ¬

²»¹ý°¡ £¬ÎÒ¸úÄã˵ £¬Õâ¸öÂÛ̳Ҳ²»ÊÇË­¶¼ÄÜÍæ×ªµÄ¡£ÄãÒªÊÇɶ¶¼²»¶® £¬Ã°Ã°Ê§Ê§¾ÍÉÏÈ¥·¢ÌûɶµÄ £¬¿ÉÄܾͱ»ÈËÇÆ²»ÉÏÁË¡£ÏñÎÒ¼ÒÂ¥ÏÂÉÕ¿¾Ì¯¶ùÄǼ¸¸öÀϸç £¬ÀÏÔÚÄǶù´µÅõ˵×Ô¼º¶®Æ·Üø £¬¿ÉÒ»µ½Õý¾­³¡ºÏ £¬Á¬²èºø¸ÇÕ¦Õû¶¼²»»á £¬Õâ²»¾Í¶ÇÓÁËÂ𠣿ÄãÉÏÂÛ̳֮ǰ £¬×îºÃÏÈ̽ѯ̽ѯ £¬¸úÀïÍ·Àϲè¿Í»ìÊìµã¶ù £¬ÔÙÍÑÊÖ¡£Äã˵ÊDz»ÊÇÓеãÏñÔÛÃǵĺȾƹæÔò £¿²»¿ÉÒ»ÉÏÀ´¾ÍÃ͹à £¬µÃÑ­Ðò½¥½ø¡£

ÕûÃ÷°×ÁË £¬²è�ÂÛ̳¾ÍÊǸö±¦²Ø

Ïà¹ØÍ¼Æ¬

×ܵÄÀ´Ëµ°É £¬Ö£Öݲè�ÂÛ̳Ëü²»¿ÉÊǸöÆ·ÜøµÄµØ¶ù £¬ÀïÃæ²Ø×ÅÈËÇéÊÀ¹Ê¡¢ÉÌ»ú £¬ÁíÓжÔÉú»îµÄ½²¾¿¡£¾ÍÏñÔÛ¶«±±µÄ´óìÀ²Ë £¬ÍâòÉÏ¿´¾ÍÒ»¹øìÀ £¬¿ÉÀïÍ·ÓÐɶÁÏ¡¢É¶»ðºò £¬Äǿɶ¼ÊÇÃŵÀ¶ù¡£ÎÒѰ˼×Ű¡ £¬ÒªÊÇÄãÄÜÕûÃ÷°×ÕâÂÛ̳ÀïµÄ·×Ó £¬ÐËÐíÄÜÀ̵½µãÀûÒæ £¬¾Í¿´ÄãÕ¦ÕûÁË¡£


ßëྵ½Õâ¶ù £¬Äã¿ÉÄÜ»¹ÏëÎÊ£º

¡°ÎÒÏÖÔÚÉÏÖ£Öݲè�ÂÛ̳ £¬»¹À´µÃ¼°²» £¿¡±

À´µÃ¼°°¡ £¬Õ¦²»À´µÃ¼°£¡ÕÕÎÒ˵°É £¬Ïȱð¼±×Å·¢Ìû £¬ÏÈÁï´ïÁï´ï £¬¶à¿´¿´Àϲè¿ÍÕ¦ßë £¬ÂýÂýÕûÃ÷°×ÁËÔÙ¼ÓÈë £¬Õâ²ÅÊÇÕý¾­Ê¶ù¡£ÄãÒªÊÇѧ»áÁË £¬±£×¼ÓÐÊÕ»ñ¡£

±êÇ©£º

    Ïà¹ØÍ¼Æ¬
  • #Ö£Öݲè�ÂÛ̳
  • #¶«±±ÈËÇéζ
  • #ßëà¾ÕÜѧ
  • #²è�ÇпÚ
  • #Éú»îÃŵÀ¶ù

¡¶°Ù×ÓÍåÃûæÂ½ÖÏÖÔÚÔõôÑùÁË¡·

ÍêÉÆÍ¶×ÊÕß±£»¤ÖƶÈ £¬ÔòÒâζ×ÅÊг¡ÖØÐÄ´Ó¡°ÈÚ×ʶ˸ïС±×ªÏòͶÈÚ×ÊÁ½¶Ë²¢ÖØ £¬Î´À´½«Ç¿»¯ÐÅÏ¢Åû¶¡¢¹¥»÷Î¥·¨Î¥¹æÐÐΪ¡¢½¡È«Åâ³¥»úÖÆ¡¢ÌáÉýÖÐСͶ×ÊÕß»ñµÃ¸Ð¡£¡°±£»¤Í¶×ÊÕß¾ÍÊDZ£»¤×ʱ¾Êг¡ÐÅÐÄ £¬ÊǺã¾Ã×ʽðÈëÊеÄǰÌá¡£¡±Ëû³Æ¡£

¡¶ºâÑôÆû³µ»ð³Ã÷ÈÕ¾ºóÃæÓÐСÏï×ÓÂð¡·

ÎâÇåÌåÏÖ £¬Ð¡°¹ú¾ÅÌõ¡±Ðû²¼ÒÔÀ´ £¬ÉÏÊй«Ë¾ÀۼƷֺì5.23ÍòÒÚÔª £¬´´Àúʷиß £¬Í¬Ê±88¼Ò¹«Ë¾Æ½ÎÈÍËÊС£

¡¶³£ÖݱÌϪŮ½ÖÕ¾×îÐÂλÖÃͼ¡·

½üÈÕ £¬¸ÃУҩѧԺÒüÀò·¼/ÐÁÏþì³/ÇØ³¬ÍŶÓÔÚȨÍþÆÚ¿¯Journal of the American Chemical SocietyÉÏÐû²¼ÌâΪ¡°Structure-Activity-Driven Multicompartment Lipid Nanoparticles for Synergistic mRNA and siRNA Codelivery in Acute Myeloid Leukemia¡±µÄÑо¿ÂÛÎÄ¡£Ò©Ñ§ÔºÒüÀò·¼½ÌÊÚ¡¢ÐÁÏþ쳸±Ñо¿Ô±¡¢Çس¬¸±½ÌÊÚºÍÖйú¿ÆÑ§ÔºÉϺ£¸ßµÈÑо¿ÔºÀîÄÈÑо¿Ô±Îª±¾ÎÄÅäºÏͨѶ×÷Õß £¬ÖйúÒ©¿Æ´óѧ2021¼¶²©Ê¿ÉúÂÀÒ»¸¦ºÍ2023¼¶Ë¶Ê¿ÉúÇØ»ÀÓîΪÅäºÏµÚÒ»×÷Õß £¬ÖйúÒ©¿Æ´óѧΪµÚһͨѶµ¥Î»¡£

ÍøÕ¾µØÍ¼